FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称MIZAGLIFLOZIN
异名/同义词3-((3-(4-((3-(.BETA.-D-GLUCOPYRANOSYLOXY)-5-(PROPAN-2-YL)-1H-PYRAZOL-4-YL)METHYL)-3-METHYLPHENOXY)PROPYL)AMINO)-2,2-DIMETHYLPROPANAMIDE
DSP-3235
DSP-3235 FREE BASE
GSK1614235 FREE BASE
GSK-1614235 FREE BASE
KGA-3235
KGA-3235 FREE BASE
MIZAGLIFLOZIN
MIZAGLIFLOZIN [INN]
MIZAGLIFLOZIN [WHO-DD]
PROPANAMIDE, 3-((3-(4-((3-(.BETA.-D-GLUCOPYRANOSYLOXY)-5-(1-METHYLETHYL)-1H-PYRAZOL-4-YL)METHYL)-3-METHYLPHENOXY)PROPYL)AMINO)-2,2-DIMETHYL-
CAS登记号666843-10-3
物质唯一标识(Unique Ingredient Identifier)1X96A704XV
分子式C28H44N4O8
国际化合物标识(International Chemical Identifier,InChI)LREHMKLEOJAVMQ-TXKDOCKMSA-N
SMILESC(c1ccc(OCCCNCC(C)(C)C(=O)N)cc1C)c2c(C(C)C)[nH]nc2O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System